Evidence map›Paper›PMID 32817456›Full record

ArticlemSphere2020

Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular Stresses.

Suraya Muzafar, Ravi Datta Sharma, Abdul Haseeb Shah, Naseem A Gaur, Ujjaini Dasgupta, Neeraj Chauhan, Rajendra Prasad

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Light controls gene functions through alternative splicing in fungi.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Transcriptomic insights intoMicrobiology spectrum · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Stress Conditions Affect the Immunomodulatory Potential ofInternational journal of molecular sciences · 2023
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Suraya MuzafarAmity Institute of Integrative Sciences and Health, Amity University Gurgaon, Gurgaon, India.
Ravi Datta SharmaAmity Institute of Integrative Sciences and Health, Amity University Gurgaon, Gurgaon, India.
Abdul Haseeb ShahDepartment of Bioresources, University of Kashmir, Srinagar, Jammu and Kashmir, India.
Naseem A GaurYeast Biofuel Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Ujjaini DasguptaAmity Institute of Integrative Sciences and Health, Amity University Gurgaon, Gurgaon, India.
Neeraj ChauhanPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA chauhan1@njms.rutgers.edu rp47jnu@gmail.com.ORCID 0000-0002-9252-9897
Rajendra PrasadAmity Institute of Integrative Sciences and Health, Amity University Gurgaon, Gurgaon, India chauhan1@njms.rutgers.edu rp47jnu@gmail.com.
Rutgers, The State University of New Jersey · USInternational Centre for Genetic Engineering and Biotechnology · INUniversity of Kashmir · IN

Funding

The Candida albicans acetylome in fungal virulenceR01AI124499 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI CHAUHAN, NEERAJ · 2016 to 2019
$1.6M
NIAID NIH HHS R01 AI124499
6 · The paper itself

Abstract

Alternative splicing (AS)-a process by which a single gene gives rise to different protein isoforms in eukaryotes-has been implicated in many basic cellular processes, but little is known about its role in drug resistance and fungal pathogenesis. The most common human fungal pathogen,

Indexed as

Alternative SplicingAntifungal AgentsAzolesCandida albicansCandidiasisDrug Resistance, FungalFungal ProteinsHumansRNA, MessengerRNA-SeqStress, PhysiologicalAntifungal AgentsAzolesFungal ProteinsRNA, Messengeralternative splicingamphotericin BCandida albicansmenadioneSOD3

Identifiers

PMID32817456
PMCPMC7426172
OpenAlexW3048380676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.